Francisco González-Saiz
Biographic Data
| ID | 7447789 |
|---|---|
| NAME | Francisco González-Saiz |
| GIVEN NAMES | Francisco |
| FAMILY NAME | González-Saiz |
| SIGNATURE | GONZÁLEZ-SAIZ F |
| AFFILIATIONS | Departamento de Neurociencias, Área de Psiquiatría, Universidad de Cádiz, Hospital Universitario de Jerez, 11407 Cádiz, Spain |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Psychometric evaluation of the opiate dosage adequacy scale: Reliability and convergent validity among non-European Spanish-speaking buprenorphine patients
Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient
In-Treatment Changes in Quality of Life-Related Variables in Therapeutic Communities for Cocaine Abusers: Are These Changes Associated with Clinical Outcomes
An improvement in quality of life-related variables from baseline to the 3-month assessment was associated with better outcomes at discharge from the therapeutic community. The findings of this study may help us to optimise therapeutic interventions
Development and validation of the scale to assess satisfaction with medications for addiction treatment – Buprenorphine-naloxone for heroin addiction (Sasmat-Bunher)
Disadvantageous Decision-Making as a Predictor of Drop-Out among Cocaine-Dependent Individuals in Long-Term Residential Treatment
Our findings suggest that neurocognitive rehabilitation of disadvantageous decision-making may have clinical benefits in CDI admitted to long-term residential treatment programs
No prominent works on this page.
Disadvantageous Decision-Making as a Predictor of Drop-Out among Cocaine-Dependent Individuals in Long-Term Residential Treatment
Our findings suggest that neurocognitive rehabilitation of disadvantageous decision-making may have clinical benefits in CDI admitted to long-term residential treatment programs
Development and validation of the scale to assess satisfaction with medications for addiction treatment – Buprenorphine-naloxone for heroin addiction (Sasmat-Bunher)
In-Treatment Changes in Quality of Life-Related Variables in Therapeutic Communities for Cocaine Abusers: Are These Changes Associated with Clinical Outcomes
An improvement in quality of life-related variables from baseline to the 3-month assessment was associated with better outcomes at discharge from the therapeutic community. The findings of this study may help us to optimise therapeutic interventions
Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient
Psychometric evaluation of the opiate dosage adequacy scale: Reliability and convergent validity among non-European Spanish-speaking buprenorphine patients
Psychiatry (4 works) · Psychology (4 works) · Buprenorphine (3 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works) · Medicine (3 works) · Opioid Use Disorder Treatment (3 works) · Substance Abuse Treatment and Outcomes (3 works) · Internal Medicine (2 works) · Opioid (2 works)